Ranbaxy Transfers Atorvastatin, Tamsulosin Filings To U.S. Ohm Labs After FDA Crackdown

Billings for valacyclovir, generic Valtrex, which Ranbaxy shifted earlier to its New Jersey affiliate, reached $100 million within the first week of the U.S. launch.

More from Archive

More from Pink Sheet